Adagene
ADAG
$2.55
Share price
4.51%
Change (1 day)
68.87%
Change (1 year)
Categories
Adagene (ADAG) - Cash on Hand
Cash on Hand as of December 2023 : $0.10 B
According to Adagene's latest financial reports the company has $0.10 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Adagene - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.14 B | -17.57% |
| 2021-12-31 | $0.17 B | 132.05% |
| 2020-12-31 | $75.15 M | -25.25% |
| 2019-12-31 | $0.10 B | 104.92% |
| 2018-12-31 | $49.05 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $5.29 M | -95.18% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | 14.08% | 🇬🇧 UK |
 Novavax NVAX | $0.56 B | 417.13% | 🇺🇸 USA |
 Novocure
NVCR | $0.87 B | 691.52% | Jersey |